Triomics, a startup building an AI-powered platform that enables oncologists and administrative staff to automate data-intensive tasks like clinical trial matching and appointment preparation, has raised $22 million in Series B funding.
The round was led by Battery Ventures with participation from returning backers Nexus Venture Partners, Lightspeed, Y Combinator and others.
The good news is that advances in oncology are extending the lives of patients. However, this welcome trend creates dense, multi-year medical records that take a long time for medical staff to review and decipher.
Typical medical records include physician progress notes, images and pathology reports, and even fax scans. “We looked at the medical records. [with] It’s thousands of pages of information,” Triomics co-founder Sarim Khan (pictured left) told TechCrunch.
Founded in 2021, the startup raised $15 million in Series A in mid-2024. Initially focused on helping physicians identify the best clinical trials for their patients, Triomics expanded its platform as its LLM capabilities grew. In recent years, Triomics has added verifiable patient summaries to its platform, allowing clinicians to view important information directly within the tools they already use, without having to switch applications.
These summaries reduce appointment preparation time and allow oncologists to spend more time with patients. Improving efficiency is important beyond individual bookings. In oncology, where patient histories are extraordinarily complex and staff burnout is an ongoing problem, tools that reduce administrative burden have a huge impact.
Triomics is also used to automate the tedious task of submitting tumor reports to government registries, which is a legal obligation for cancer centers.
While general purpose AI agents are great for basic summaries, prominent institutions like Memorial Sloan Kettering (MSK) and Yale Cancer Center use Triomics. That's because the model is specifically trained on oncology data, Khan explained.
Triomics' most direct competitors are AI medical scribes like Abridge and Microsoft's Nuance (tools that use AI to listen and document conversations between patients and doctors) when it comes to summarizing patient medical records.
Despite fierce competition, Triomics is growing rapidly. Khan said the startup has quadrupled its enterprise customer base and driven 10x annual recurring revenue growth over the past year.
If you buy through links in our articles, we may earn a small commission. This does not affect editorial independence.